Mawdsleys Host Webinar on Named Patient Programmes

Mawdsleys Host Webinar on Named Patient Programmes 14th September 2017

Mawdsleys is hosting a webinar to help people in the healthcare sector and pharmaceutical industry develop a deeper understanding of Named Patient Programmes. Participants of the webinar will hear how named patient programmes can be successfully implemented to treat patients who need a medicine that is not locally available to them.

Content will be presented by Dr Alain Zeitoun, Mawdsleys’ Named Patient programs Medical and Science Liaison, and Richard Leach, Mawdsleys’ Named Patient Program Manager.

The webinar will be held on 27th September 2017 at 3PM London / 10AM New York.

For further information, or to register for the webinar, please click here

If you would like to speak to somebody at Mawdsleys about Named Patient Programmes please contact info@mawdsleys.co.uk

Other latest news

Mawdsleys Pre-Wholesale selected as 3PL logistics service provider of choice by Daiichi Sankyo UK Ltd

Daiichi Sankyo approached Mawdsleys’ Pre-Wholesale (MPW) in January 2016; seeking a flexible, cost effective pre-wholesale distributor, that excelled in efficiency. Actions/Results: After discussing Daiichi Sankyo’s requirements, MPW successfully delivered an integration of Daiichi Sankyo’s SAP (Systems Applications Products) IT systems and Mawdsleys’ IT software; in turn allowing…

Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer. BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…